MD-Onco journal was founded in 2021. The first issue was published in November 2021 and was presented at the Russian Cancer Congress.

MD-Onco journal is an interdisciplinary scientific publication that unites oncologists, surgeons, radiation therapists, anesthesiologists, resuscitators, hematologists, clinical pharmacologists, molecular biologists and other specialists to create a comprehensive interdisciplinary approach to therapy in order to improve the effectiveness of treatment of patients with oncological diseases.

The journal presents the most up-to-date information on clinical, clinical-experimental and fundamental scientific works, on modern achievements, including the latest methods of diagnosis and treatment of tumors, as well as malignant diseases of the blood system.

The subject matter of the MD-Onco journal's publications lies in the plane of the interests of doctors of various specialties who provide advisory and therapeutic care to cancer patients.

The MD-Onco edition is attended by Russian experts, in particular from the "Lapino 2" Oncology Center of the "Mother and Child" group of companies. The clinical departments at the Center are led by the leaders of the areas of surgery in our country, and some in Europe.